460 related articles for article (PubMed ID: 14559981)
1. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
2. Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma.
Rao UN; Bakker A; Swalsky PA; Finkelstein SD
Mod Pathol; 1999 Apr; 12(4):344-50. PubMed ID: 10229497
[TBL] [Abstract][Full Text] [Related]
3. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
[TBL] [Abstract][Full Text] [Related]
4. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
5. Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK
Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509
[TBL] [Abstract][Full Text] [Related]
6. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells.
Wechsler DS; Shelly CA; Petroff CA; Dang CV
Cancer Res; 1997 Nov; 57(21):4905-12. PubMed ID: 9354456
[TBL] [Abstract][Full Text] [Related]
7. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Hong WK; Mao L
Oncogene; 1998 Oct; 17(13):1749-53. PubMed ID: 9796705
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
10. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer.
Prochownik EV; Eagle Grove L; Deubler D; Zhu XL; Stephenson RA; Rohr LR; Yin X; Brothman AR
Genes Chromosomes Cancer; 1998 Aug; 22(4):295-304. PubMed ID: 9669667
[TBL] [Abstract][Full Text] [Related]
11. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.
Katona TM; Jones TD; Wang M; Eble JN; Billings SD; Cheng L
Am J Surg Pathol; 2007 Jul; 31(7):1029-37. PubMed ID: 17592269
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the MXI1 gene in prostate cancer.
Eagle LR; Yin X; Brothman AR; Williams BJ; Atkin NB; Prochownik EV
Nat Genet; 1995 Mar; 9(3):249-55. PubMed ID: 7773287
[TBL] [Abstract][Full Text] [Related]
13. Morphologic diversity in malignant melanoma: the potential use of microdissection and the polymerase chain reaction for diagnosis.
Quezado MM; Abati AD; Albuquerque AV; Wilson J; Merino MJ; Filie AC
Mod Pathol; 1998 Oct; 11(10):1010-5. PubMed ID: 9796732
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A mutation and deletion status in thin and thick primary melanoma.
Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
[TBL] [Abstract][Full Text] [Related]
15. Genotypic analysis of primary and metastatic cutaneous melanoma.
Rao UN; Jones MW; Finkelstein SD
Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
[TBL] [Abstract][Full Text] [Related]
17. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
19. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
20. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
